 | • レポートコード：GIR-2104Z06332 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥494,160 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥741,240 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥988,320 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、消化器がん治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。消化器がん治療薬の種類別市場規模（腫瘍、放射線、その他）、用途別市場規模（病院、専門がん治療センター、クリニック、外来手術センター）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・消化器がん治療薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Amgen & Amgen Ireland、Bristol-Myers Squibb Company、Roche、Eli Lilly and Company、Johnson & Johnson Private、GlaxoSmithKline、Celgene Corporation、Pfizer、Sanofi、Novartis ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：腫瘍、放射線、その他 ・用途別分析2016年-2026年：病院、専門がん治療センター、クリニック、外来手術センター ・消化器がん治療薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・消化器がん治療薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・消化器がん治療薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・消化器がん治療薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・消化器がん治療薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Gastrointestinal Cancer Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Gastrointestinal Cancer Drugs size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Gastrointestinal Cancer Drugs market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Gastrointestinal Cancer Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Oncology
Radiology
Others
Market segment by Application can be divided into
Hospitals
Specialized Cancer Treatment Centers
Clinics
Ambulatory Surgical Centers
The key market players for global Gastrointestinal Cancer Drugs market are listed below:
Amgen & Amgen Ireland
Bristol-Myers Squibb Company
Roche
Eli Lilly and Company
Johnson & Johnson Private
GlaxoSmithKline
Celgene Corporation
Pfizer
Sanofi
Novartis
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Gastrointestinal Cancer Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Gastrointestinal Cancer Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Oncology
1.2.3 Radiology
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Gastrointestinal Cancer Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Specialized Cancer Treatment Centers
1.3.4 Clinics
1.3.5 Ambulatory Surgical Centers
1.4 Global Gastrointestinal Cancer Drugs Market Size & Forecast
1.4.1 Global Gastrointestinal Cancer Drugs Sales in Value (2016-2026))
1.4.2 Global Gastrointestinal Cancer Drugs Sales in Volume (2016-2026)
1.4.3 Global Gastrointestinal Cancer Drugs Price by Type (2016-2026) & (USD/Unit)
1.5 Global Gastrointestinal Cancer Drugs Production Capacity Analysis
1.5.1 Global Gastrointestinal Cancer Drugs Total Production Capacity (2016-2026)
1.5.2 Global Gastrointestinal Cancer Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Gastrointestinal Cancer Drugs Market Drivers
1.6.2 Gastrointestinal Cancer Drugs Market Restraints
1.6.3 Gastrointestinal Cancer Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Amgen & Amgen Ireland
2.1.1 Amgen & Amgen Ireland Details
2.1.2 Amgen & Amgen Ireland Major Business
2.1.3 Amgen & Amgen Ireland Gastrointestinal Cancer Drugs Product and Services
2.1.4 Amgen & Amgen Ireland Gastrointestinal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Bristol-Myers Squibb Company
2.2.1 Bristol-Myers Squibb Company Details
2.2.2 Bristol-Myers Squibb Company Major Business
2.2.3 Bristol-Myers Squibb Company Gastrointestinal Cancer Drugs Product and Services
2.2.4 Bristol-Myers Squibb Company Gastrointestinal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Roche
2.3.1 Roche Details
2.3.2 Roche Major Business
2.3.3 Roche Gastrointestinal Cancer Drugs Product and Services
2.3.4 Roche Gastrointestinal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Eli Lilly and Company
2.4.1 Eli Lilly and Company Details
2.4.2 Eli Lilly and Company Major Business
2.4.3 Eli Lilly and Company Gastrointestinal Cancer Drugs Product and Services
2.4.4 Eli Lilly and Company Gastrointestinal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Johnson & Johnson Private
2.5.1 Johnson & Johnson Private Details
2.5.2 Johnson & Johnson Private Major Business
2.5.3 Johnson & Johnson Private Gastrointestinal Cancer Drugs Product and Services
2.5.4 Johnson & Johnson Private Gastrointestinal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 GlaxoSmithKline
2.6.1 GlaxoSmithKline Details
2.6.2 GlaxoSmithKline Major Business
2.6.3 GlaxoSmithKline Gastrointestinal Cancer Drugs Product and Services
2.6.4 GlaxoSmithKline Gastrointestinal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Celgene Corporation
2.7.1 Celgene Corporation Details
2.7.2 Celgene Corporation Major Business
2.7.3 Celgene Corporation Gastrointestinal Cancer Drugs Product and Services
2.7.4 Celgene Corporation Gastrointestinal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business
2.8.3 Pfizer Gastrointestinal Cancer Drugs Product and Services
2.8.4 Pfizer Gastrointestinal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Sanofi
2.9.1 Sanofi Details
2.9.2 Sanofi Major Business
2.9.3 Sanofi Gastrointestinal Cancer Drugs Product and Services
2.9.4 Sanofi Gastrointestinal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Novartis
2.10.1 Novartis Details
2.10.2 Novartis Major Business
2.10.3 Novartis Gastrointestinal Cancer Drugs Product and Services
2.10.4 Novartis Gastrointestinal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Gastrointestinal Cancer Drugs Sales by Manufacturer
3.1 Global Gastrointestinal Cancer Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Gastrointestinal Cancer Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Gastrointestinal Cancer Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Gastrointestinal Cancer Drugs Manufacturer Market Share
3.4.2 Top 6 Gastrointestinal Cancer Drugs Manufacturer Market Share
3.5 Global Gastrointestinal Cancer Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Gastrointestinal Cancer Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Gastrointestinal Cancer Drugs Market Size by Region
4.1.1 Global Gastrointestinal Cancer Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Gastrointestinal Cancer Drugs Revenue by Region (2016-2026)
4.2 North America Gastrointestinal Cancer Drugs Revenue (2016-2026)
4.3 Europe Gastrointestinal Cancer Drugs Revenue (2016-2026)
4.4 Asia-Pacific Gastrointestinal Cancer Drugs Revenue (2016-2026)
4.5 South America Gastrointestinal Cancer Drugs Revenue (2016-2026)
4.6 Middle East and Africa Gastrointestinal Cancer Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Gastrointestinal Cancer Drugs Sales in Volume by Type (2016-2026)
5.2 Global Gastrointestinal Cancer Drugs Revenue by Type (2016-2026)
5.3 Global Gastrointestinal Cancer Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Gastrointestinal Cancer Drugs Sales in Volume by Application (2016-2026)
6.2 Global Gastrointestinal Cancer Drugs Revenue by Application (2016-2026)
6.3 Global Gastrointestinal Cancer Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Gastrointestinal Cancer Drugs Sales by Type (2016-2026)
7.2 North America Gastrointestinal Cancer Drugs Sales by Application (2016-2026)
7.3 North America Gastrointestinal Cancer Drugs Market Size by Country
7.3.1 North America Gastrointestinal Cancer Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Gastrointestinal Cancer Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Gastrointestinal Cancer Drugs Sales by Type (2016-2026)
8.2 Europe Gastrointestinal Cancer Drugs Sales by Application (2016-2026)
8.3 Europe Gastrointestinal Cancer Drugs Market Size by Country
8.3.1 Europe Gastrointestinal Cancer Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Gastrointestinal Cancer Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Gastrointestinal Cancer Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Gastrointestinal Cancer Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Gastrointestinal Cancer Drugs Market Size by Region
9.3.1 Asia-Pacific Gastrointestinal Cancer Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Gastrointestinal Cancer Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Gastrointestinal Cancer Drugs Sales by Type (2016-2026)
10.2 South America Gastrointestinal Cancer Drugs Sales by Application (2016-2026)
10.3 South America Gastrointestinal Cancer Drugs Market Size by Country
10.3.1 South America Gastrointestinal Cancer Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Gastrointestinal Cancer Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Gastrointestinal Cancer Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Gastrointestinal Cancer Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Gastrointestinal Cancer Drugs Market Size by Country
11.3.1 Middle East & Africa Gastrointestinal Cancer Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Gastrointestinal Cancer Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Gastrointestinal Cancer Drugs Typical Distributors
12.3 Gastrointestinal Cancer Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Gastrointestinal Cancer Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Gastrointestinal Cancer Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. Amgen & Amgen Ireland Basic Information, Manufacturing Base and Competitors
Table 4. Amgen & Amgen Ireland Major Business
Table 5. Amgen & Amgen Ireland Gastrointestinal Cancer Drugs Product and Services
Table 6. Amgen & Amgen Ireland Gastrointestinal Cancer Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table 8. Bristol-Myers Squibb Company Major Business
Table 9. Bristol-Myers Squibb Company Gastrointestinal Cancer Drugs Product and Services
Table 10. Bristol-Myers Squibb Company Gastrointestinal Cancer Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Roche Basic Information, Manufacturing Base and Competitors
Table 12. Roche Major Business
Table 13. Roche Gastrointestinal Cancer Drugs Product and Services
Table 14. Roche Gastrointestinal Cancer Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 16. Eli Lilly and Company Major Business
Table 17. Eli Lilly and Company Gastrointestinal Cancer Drugs Product and Services
Table 18. Eli Lilly and Company Gastrointestinal Cancer Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Johnson & Johnson Private Basic Information, Manufacturing Base and Competitors
Table 20. Johnson & Johnson Private Major Business
Table 21. Johnson & Johnson Private Gastrointestinal Cancer Drugs Product and Services
Table 22. Johnson & Johnson Private Gastrointestinal Cancer Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 24. GlaxoSmithKline Major Business
Table 25. GlaxoSmithKline Gastrointestinal Cancer Drugs Product and Services
Table 26. GlaxoSmithKline Gastrointestinal Cancer Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Celgene Corporation Basic Information, Manufacturing Base and Competitors
Table 28. Celgene Corporation Major Business
Table 29. Celgene Corporation Gastrointestinal Cancer Drugs Product and Services
Table 30. Celgene Corporation Gastrointestinal Cancer Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Pfizer Basic Information, Manufacturing Base and Competitors
Table 32. Pfizer Major Business
Table 33. Pfizer Gastrointestinal Cancer Drugs Product and Services
Table 34. Pfizer Gastrointestinal Cancer Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Sanofi Basic Information, Manufacturing Base and Competitors
Table 36. Sanofi Major Business
Table 37. Sanofi Gastrointestinal Cancer Drugs Product and Services
Table 38. Sanofi Gastrointestinal Cancer Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Novartis Basic Information, Manufacturing Base and Competitors
Table 40. Novartis Major Business
Table 41. Novartis Gastrointestinal Cancer Drugs Product and Services
Table 42. Novartis Gastrointestinal Cancer Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Global Gastrointestinal Cancer Drugs Sales by Manufacturer (2019-2021e) & (K Units)
Table 44. Global Gastrointestinal Cancer Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 45. Market Position of Manufacturers in Gastrointestinal Cancer Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 46. Global Gastrointestinal Cancer Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 47. Head Office and Gastrointestinal Cancer Drugs Production Site of Key Manufacturer
Table 48. Global Gastrointestinal Cancer Drugs Sales by Region (2016-2021e) & (K Units)
Table 49. Global Gastrointestinal Cancer Drugs Sales by Region (2021-2026) & (K Units)
Table 50. Global Gastrointestinal Cancer Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 51. Global Gastrointestinal Cancer Drugs Revenue by Region (2021-2026) & (USD Million)
Table 52. Global Gastrointestinal Cancer Drugs Sales by Type (2016-2021e) & (K Units)
Table 53. Global Gastrointestinal Cancer Drugs Sales by Type (2021-2026) & (K Units)
Table 54. Global Gastrointestinal Cancer Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 55. Global Gastrointestinal Cancer Drugs Revenue by Type (2021-2026) & (USD Million)
Table 56. Global Gastrointestinal Cancer Drugs Price by Type (2016-2021e) & (USD/Unit)
Table 57. Global Gastrointestinal Cancer Drugs Price by Type (2021-2026) & (USD/Unit)
Table 58. Global Gastrointestinal Cancer Drugs Sales by Application (2016-2021e) & (K Units)
Table 59. Global Gastrointestinal Cancer Drugs Sales by Application (2021-2026) & (K Units)
Table 60. Global Gastrointestinal Cancer Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 61. Global Gastrointestinal Cancer Drugs Revenue by Application (2021-2026) & (USD Million)
Table 62. Global Gastrointestinal Cancer Drugs Price by Application (2016-2021e) & (USD/Unit)
Table 63. Global Gastrointestinal Cancer Drugs Price by Application (2021-2026) & (USD/Unit)
Table 64. North America Gastrointestinal Cancer Drugs Sales by Country (2016-2021e) & (K Units)
Table 65. North America Gastrointestinal Cancer Drugs Sales by Country (2021-2026) & (K Units)
Table 66. North America Gastrointestinal Cancer Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 67. North America Gastrointestinal Cancer Drugs Revenue by Country (2021-2026) & (USD Million)
Table 68. North America Gastrointestinal Cancer Drugs Sales by Type (2016-2021e) & (K Units)
Table 69. North America Gastrointestinal Cancer Drugs Sales by Type (2021-2026) & (K Units)
Table 70. North America Gastrointestinal Cancer Drugs Sales by Application (2016-2021e) & (K Units)
Table 71. North America Gastrointestinal Cancer Drugs Sales by Application (2021-2026) & (K Units)
Table 72. Europe Gastrointestinal Cancer Drugs Sales by Country (2016-2021e) & (K Units)
Table 73. Europe Gastrointestinal Cancer Drugs Sales by Country (2021-2026) & (K Units)
Table 74. Europe Gastrointestinal Cancer Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 75. Europe Gastrointestinal Cancer Drugs Revenue by Country (2021-2026) & (USD Million)
Table 76. Europe Gastrointestinal Cancer Drugs Sales by Type (2016-2021e) & (K Units)
Table 77. Europe Gastrointestinal Cancer Drugs Sales by Type (2021-2026) & (K Units)
Table 78. Europe Gastrointestinal Cancer Drugs Sales by Application (2016-2021e) & (K Units)
Table 79. Europe Gastrointestinal Cancer Drugs Sales by Application (2021-2026) & (K Units)
Table 80. Asia-Pacific Gastrointestinal Cancer Drugs Sales by Region (2016-2021e) & (K Units)
Table 81. Asia-Pacific Gastrointestinal Cancer Drugs Sales by Region (2021-2026) & (K Units)
Table 82. Asia-Pacific Gastrointestinal Cancer Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 83. Asia-Pacific Gastrointestinal Cancer Drugs Revenue by Region (2021-2026) & (USD Million)
Table 84. Asia-Pacific Gastrointestinal Cancer Drugs Sales by Type (2016-2021e) & (K Units)
Table 85. Asia-Pacific Gastrointestinal Cancer Drugs Sales by Type (2021-2026) & (K Units)
Table 86. Asia-Pacific Gastrointestinal Cancer Drugs Sales by Application (2016-2021e) & (K Units)
Table 87. Asia-Pacific Gastrointestinal Cancer Drugs Sales by Application (2021-2026) & (K Units)
Table 88. South America Gastrointestinal Cancer Drugs Sales by Country (2016-2021e) & (K Units)
Table 89. South America Gastrointestinal Cancer Drugs Sales by Country (2021-2026) & (K Units)
Table 90. South America Gastrointestinal Cancer Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 91. South America Gastrointestinal Cancer Drugs Revenue by Country (2021-2026) & (USD Million)
Table 92. South America Gastrointestinal Cancer Drugs Sales by Type (2016-2021e) & (K Units)
Table 93. South America Gastrointestinal Cancer Drugs Sales by Type (2021-2026) & (K Units)
Table 94. South America Gastrointestinal Cancer Drugs Sales by Application (2016-2021e) & (K Units)
Table 95. South America Gastrointestinal Cancer Drugs Sales by Application (2021-2026) & (K Units)
Table 96. Middle East & Africa Gastrointestinal Cancer Drugs Sales by Country (2016-2021e) & (K Units)
Table 97. Middle East & Africa Gastrointestinal Cancer Drugs Sales by Country (2021-2026) & (K Units)
Table 98. Middle East & Africa Gastrointestinal Cancer Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 99. Middle East & Africa Gastrointestinal Cancer Drugs Revenue by Country (2021-2026) & (USD Million)
Table 100. Middle East & Africa Gastrointestinal Cancer Drugs Sales by Type (2016-2021e) & (K Units)
Table 101. Middle East & Africa Gastrointestinal Cancer Drugs Sales by Type (2021-2026) & (K Units)
Table 102. Middle East & Africa Gastrointestinal Cancer Drugs Sales by Application (2016-2021e) & (K Units)
Table 103. Middle East & Africa Gastrointestinal Cancer Drugs Sales by Application (2021-2026) & (K Units)
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Gastrointestinal Cancer Drugs Typical Distributors
Table 107. Gastrointestinal Cancer Drugs Typical Customers
List of Figures
Figure 1. Gastrointestinal Cancer Drugs Picture
Figure 2. Global Gastrointestinal Cancer Drugs Sales Market Share by Type in 2020
Figure 3. Oncology
Figure 4. Radiology
Figure 5. Others
Figure 6. Global Gastrointestinal Cancer Drugs Sales Market Share by Application in 2020
Figure 7. Hospitals
Figure 8. Specialized Cancer Treatment Centers
Figure 9. Clinics
Figure 10. Ambulatory Surgical Centers
Figure 11. Global Gastrointestinal Cancer Drugs Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 12. Global Gastrointestinal Cancer Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 13. United States Gastrointestinal Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Canada Gastrointestinal Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Mexico Gastrointestinal Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Germany Gastrointestinal Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. France Gastrointestinal Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. United Kingdom Gastrointestinal Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Russia Gastrointestinal Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Italy Gastrointestinal Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. China Gastrointestinal Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Japan Gastrointestinal Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Korea Gastrointestinal Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. India Gastrointestinal Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Southeast Asia Gastrointestinal Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Australia Gastrointestinal Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Brazil Gastrointestinal Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Egypt Gastrointestinal Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Saudi Arabia Gastrointestinal Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. South Africa Gastrointestinal Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Turkey Gastrointestinal Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Global Gastrointestinal Cancer Drugs Sales (2016-2026) & (K Units)
Figure 33. Global Gastrointestinal Cancer Drugs Production Capacity (2016-2026) & (K Units)
Figure 34. Global Gastrointestinal Cancer Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 35. Gastrointestinal Cancer Drugs Market Drivers
Figure 36. Gastrointestinal Cancer Drugs Market Restraints
Figure 37. Gastrointestinal Cancer Drugs Market Trends
Figure 38. Global Gastrointestinal Cancer Drugs Sales Market Share by Manufacturer in 2020
Figure 39. Global Gastrointestinal Cancer Drugs Revenue Market Share by Manufacturer in 2020
Figure 40. Gastrointestinal Cancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 41. Top 3 Gastrointestinal Cancer Drugs Manufacturer (Revenue) Market Share in 2020
Figure 42. Top 6 Gastrointestinal Cancer Drugs Manufacturer (Revenue) Market Share in 2020
Figure 43. Global Gastrointestinal Cancer Drugs Sales Market Share by Region (2016-2026)
Figure 44. Global Gastrointestinal Cancer Drugs Revenue Market Share by Region (2016-2026)
Figure 45. North America Gastrointestinal Cancer Drugs Revenue (2016-2026) & (USD Million)
Figure 46. Europe Gastrointestinal Cancer Drugs Revenue (2016-2026) & (USD Million)
Figure 47. Asia-Pacific Gastrointestinal Cancer Drugs Revenue (2016-2026) & (USD Million)
Figure 48. South America Gastrointestinal Cancer Drugs Revenue (2016-2026) & (USD Million)
Figure 49. Middle East & Africa Gastrointestinal Cancer Drugs Revenue (2016-2026) & (USD Million)
Figure 50. Global Gastrointestinal Cancer Drugs Sales Market Share by Type (2016-2026)
Figure 51. Global Gastrointestinal Cancer Drugs Revenue Market Share by Type (2016-2026)
Figure 52. Global Gastrointestinal Cancer Drugs Price by Type (2016-2026) & (USD/Unit)
Figure 53. Global Gastrointestinal Cancer Drugs Sales Market Share by Application (2016-2026)
Figure 54. Global Gastrointestinal Cancer Drugs Revenue Market Share by Application (2016-2026)
Figure 55. Global Gastrointestinal Cancer Drugs Price by Application (2016-2026) & (USD/Unit)
Figure 56. North America Gastrointestinal Cancer Drugs Sales Market Share by Country (2016-2026)
Figure 57. North America Gastrointestinal Cancer Drugs Revenue Market Share by Country (2016-2026)
Figure 58. North America Gastrointestinal Cancer Drugs Sales Market Share by Type (2016-2026)
Figure 59. North America Gastrointestinal Cancer Drugs Sales Market Share by Application (2016-2026)
Figure 60. Europe Gastrointestinal Cancer Drugs Sales Market Share by Country (2016-2026)
Figure 61. Europe Gastrointestinal Cancer Drugs Revenue Market Share by Country (2016-2026)
Figure 62. Europe Gastrointestinal Cancer Drugs Sales Market Share by Type (2016-2026)
Figure 63. Europe Gastrointestinal Cancer Drugs Sales Market Share by Application (2016-2026)
Figure 64. Asia-Pacific Gastrointestinal Cancer Drugs Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Gastrointestinal Cancer Drugs Revenue Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Gastrointestinal Cancer Drugs Sales Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Gastrointestinal Cancer Drugs Sales Market Share by Application (2016-2026)
Figure 68. South America Gastrointestinal Cancer Drugs Sales Market Share by Country (2016-2026)
Figure 69. South America Gastrointestinal Cancer Drugs Revenue Market Share by Country (2016-2026)
Figure 70. South America Gastrointestinal Cancer Drugs Sales Market Share by Type (2016-2026)
Figure 71. South America Gastrointestinal Cancer Drugs Sales Market Share by Application (2016-2026)
Figure 72. Middle East & Africa Gastrointestinal Cancer Drugs Sales Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Gastrointestinal Cancer Drugs Revenue Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Gastrointestinal Cancer Drugs Sales Market Share by Type (2016-2026)
Figure 75. Middle East & Africa Gastrointestinal Cancer Drugs Sales Market Share by Application (2016-2026)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source
世界の消化器がんデバイス市場 2021：企業別、地域別、種類・用途別 The Gastrointestinal Cancer Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade…- 世界の消化器がん治療市場 2021：企業別、地域別、種類・用途別 The Gastrointestinal Cancer Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tra…
- 世界の肺がん治療薬市場規模・現状・予測（2021年-2027年） Lung Cancer Treatment Drugs are durgs used to cure lung cancer. In the coming years, it is expected that the global Lung Cancer Treatment Drugs market will advance with higher growth rate as compared to previous years. Factors such as Smoking, Rising cases of infections, Rising rates of fast growing…
- 世界の膵臓がん治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Pancreatic Cancer Treatment Drugs Market The global Pancreatic Cancer Treatment Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high da…
- 世界の膵臓がん治療薬市場 2021：企業別、地域別、種類・用途別 The Pancreatic Cancer Treatment Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tra…